Bumper Offer - Urjas oil Just @ Rs. 1
Zidolam N N is a commercial drug that is prescribed in the form of Tablet. Zidolam N N also has some secondary and off-label uses. These are listed below.
The correct dosage of Zidolam N N depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Zidolam N N side effects, there are can be others also. These have been listed below. These side effects of Zidolam N N are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Zidolam N N's effect is Safe during pregnancy and Safe for lactating mothers. In addition, Zidolam N N's effects on the liver, heart and kidney are discussed below in the Zidolam N N related warnings section.
Zidolam N N is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease, Pancreatitis, Kidney Disease are examples of such conditions. Other conditions have been mentioned below in the Zidolam N N contraindications section.
Additionally, Zidolam N N may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Zidolam N N, it is important to know that it is not safe while driving, and is not habit-forming.
Zidolam N N is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Zidolam N N is used -
Moderate
Mild
Is the use of Zidolam N N safe for pregnant women?
Zidolam N N is safe for pregnant women.
Is the use of Zidolam N N safe during breastfeeding?
Breastfeeding women can safely use Zidolam N N.
What is the effect of Zidolam N N on the Kidneys?
Zidolam N N does not damage the kidneys.
What is the effect of Zidolam N N on the Liver?
Zidolam N N has very mild side effects on the liver.
What is the effect of Zidolam N N on the Heart?
Zidolam N N is not harmful for the heart.
Zidolam N N should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Zidolam N N unless your doctor advises you to do so -
Is this Zidolam N N habit forming or addictive?
Zidolam N N is not addictive in nature.
Interaction between Food and Zidolam N N
You can take Zidolam N N with food.
Interaction between Alcohol and Zidolam N N
Information about the interaction of Zidolam N N and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Epivir (lamivudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807-808
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 96-99
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retrovir® (zidovudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 806-807
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1286-1288
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Viramune® (nevirapine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 809
